These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34905402)
1. Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs. Karami TK; Hailu S; Feng S; Graham R; Gukasyan HJ J Ocul Pharmacol Ther; 2022; 38(1):43-55. PubMed ID: 34905402 [TBL] [Abstract][Full Text] [Related]
2. Molecular design for enhancement of ocular penetration. Shirasaki Y J Pharm Sci; 2008 Jul; 97(7):2462-96. PubMed ID: 17918725 [TBL] [Abstract][Full Text] [Related]
3. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five. Chen X; Li H; Tian L; Li Q; Luo J; Zhang Y J Comput Biol; 2020 Sep; 27(9):1397-1406. PubMed ID: 32031890 [TBL] [Abstract][Full Text] [Related]
5. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900 [TBL] [Abstract][Full Text] [Related]
6. Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation. Hou Y; Zhang F; Lan J; Sun F; Li J; Li M; Song K; Wu X Drug Deliv; 2019 Dec; 26(1):158-167. PubMed ID: 30822157 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats. Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367 [TBL] [Abstract][Full Text] [Related]
8. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking. Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681 [TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232 [TBL] [Abstract][Full Text] [Related]
11. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Jiao J Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195 [TBL] [Abstract][Full Text] [Related]
12. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Choy YB; Prausnitz MR Pharm Res; 2011 May; 28(5):943-8. PubMed ID: 20967491 [TBL] [Abstract][Full Text] [Related]
13. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension. Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305 [TBL] [Abstract][Full Text] [Related]